title: Gastroesophageal reflux disease and Helicobacter pylori infection.
abstract: The prevalence of Helicobacter pylori infection has been decreasing while the prevalence of gastroesophageal reflux disease and esophageal adenocarcinoma has been increasing in developed countries since the 1930s. This has raised concerns that H. pylori infection may protect against esophageal disease and that the disappearance of H. pylori from the population might lead to a further increase in gastroesophageal reflux disease. Some studies have suggested that eradication of H. pylori in patients with duodenal ulcer disease results in an increase in the incidence of erosive esophagitis, whereas other studies have shown no such increase. Studies on gastric acid secretion have demonstrated that proton pump inhibitors are more effective in controlling gastric pH in individuals who are infected with H. pylori. Studies on the impact of therapy in patients with erosive esophagitis have been conflicting. This article reviews each of the issues in the debate separately and concludes that there is little evidence to suggest a major effect of H. pylori eradication on the outcome of gastroesophageal reflux disease.
authors.affiliation: Section of Gastroenterology, Department of Medicine, University of Wisconsin Medical School, Milwaukee, WI, USA.
authors.forename: Nimish
authors.initials: N
authors.lastname: Vakil
mesh_terms: D000328:Adult; D004941:Esophagitis / Q000382:microbiology; D005756:Gastritis / Q000382:microbiology; D005764:Gastroesophageal Reflux / Q000382:microbiology*; D016481:Helicobacter Infections / Q000150:complications*; D016480:Helicobacter pylori; D006801:Humans; D008297:Male; D054328:Proton Pump Inhibitors; D012008:Recurrence
chemical_list: D054328:Proton Pump Inhibitors